🚀 VC round data is live in beta, check it out!
Predilife Valuation Multiples
Discover revenue and EBITDA valuation multiples for Predilife and similar public comparables like Biomaxima, Immunovia, Biosynex, Synthetic MR and more.
Predilife Overview
About Predilife
Predilife SA develops solutions for predictive medicine, combining medical techniques (genetic tests, medical imaging) and mathematical models with a large amount of statistical data, which allows each individual to define their risk profile for the occurrence of various serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
Founded
2008
HQ
Employees
19
Website
Financials (FY)
EV
$20M
Predilife Financials
Predilife reported last fiscal year revenue of $728K and negative EBITDA of ($5M).
In the same fiscal year, Predilife generated $711K in gross profit, ($5M) in EBITDA losses, and $234M in net income.
Predilife P&L
In the most recent fiscal year, Predilife reported revenue of $728K and EBITDA of ($5M).
Predilife expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $728K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $711K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 98% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (639%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (645%) | XXX | XXX | XXX |
| Net Profit | — | XXX | $234M | XXX | XXX | XXX |
| Net Margin | — | XXX | 32137% | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Predilife Stock Performance
Predilife has current market cap of $14M, and enterprise value of $20M.
Market Cap Evolution
Predilife's stock price is $3.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20M | $14M | -0.1% | XXX | XXX | XXX | $59.66 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPredilife Valuation Multiples
Predilife trades at 27.1x EV/Revenue multiple, and (4.2x) EV/EBITDA.
Predilife Financial Valuation Multiples
As of April 20, 2026, Predilife has market cap of $14M and EV of $20M.
Equity research analysts estimate Predilife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Predilife has a P/E ratio of 0.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14M | XXX | $14M | XXX | XXX | XXX |
| EV (current) | $20M | XXX | $20M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 27.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 27.7x | XXX | XXX | XXX |
| P/E | — | XXX | 0.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Predilife Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Predilife Margins & Growth Rates
Predilife's revenue in the last fiscal year grew by 94%.
Predilife's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Predilife Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 94% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (639%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 4% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 743% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Predilife Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Predilife | XXX | XXX | XXX | XXX | XXX | XXX |
| Biomaxima | XXX | XXX | XXX | XXX | XXX | XXX |
| Immunovia | XXX | XXX | XXX | XXX | XXX | XXX |
| Biosynex | XXX | XXX | XXX | XXX | XXX | XXX |
| Synthetic MR | XXX | XXX | XXX | XXX | XXX | XXX |
| Genomed | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Predilife M&A Activity
Predilife acquired XXX companies to date.
Last acquisition by Predilife was on XXXXXXXX, XXXXX. Predilife acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Predilife
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPredilife Investment Activity
Predilife invested in XXX companies to date.
Predilife made its latest investment on XXXXXXXX, XXXXX. Predilife invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Predilife
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Predilife
| When was Predilife founded? | Predilife was founded in 2008. |
| Where is Predilife headquartered? | Predilife is headquartered in France. |
| How many employees does Predilife have? | As of today, Predilife has over 19 employees. |
| Is Predilife publicly listed? | Yes, Predilife is a public company listed on Euronext Paris. |
| What is the stock symbol of Predilife? | Predilife trades under ALPRE ticker. |
| When did Predilife go public? | Predilife went public in 2018. |
| Who are competitors of Predilife? | Predilife main competitors are Biomaxima, Immunovia, Biosynex, Synthetic MR. |
| What is the current market cap of Predilife? | Predilife's current market cap is $14M. |
| What is the current revenue of Predilife? | Predilife's last fiscal year revenue is $728K. |
| What is the current EV/Revenue multiple of Predilife? | Current revenue multiple of Predilife is 27.1x. |
| Is Predilife profitable? | No, Predilife is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.